BCLC Ergothioneine–Curcumin–Piperine Core–Shell Nanolipid Carrier for Synchronized Release, Improved Stability, and Translational Antioxidant–Anti-Inflammatory Synergy
International Journal of Agriculture and Food Sciences Research · 29.04.2026 · 4 (1) · 83-92
DOI: 10.62051/ijafsr.v4n1.08 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Agriculture and Food Sciences Research, online erschienen am 29.04.2026. Verfasst von Nour-Eddine Ziraoui und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
We developed BCLC as a core–shell nanolipid carrier to organize three physicochemically mismatched yet mechanistically complementary actives—ergothioneine (EGT), curcumin, and piperine—within a single delivery architecture. We positioned curcumin in a hydrophobic lipid core, enriched piperine at the interfacial layer, and anchored EGT on a hydrophilic shell, then evaluated particle characteristics, encapsulation efficiency, release behavior, and long-term stability across disclosed embodiments and comparators. The lead embodiment achieved a particle size of 32.6 nm, PDI 0.087, zeta potential −41.2 mV, and encapsulation efficiencies of 96.8%, 95.3%, and 94.7% for EGT, curcumin, and piperine, respectively. At 24 h, cumulative release reached 76.3%, 74.1%, and 77.8%, indicating synchronized release of all three actives, whereas the physical-mixture comparator displayed burst release for EGT and piperine but poor curcumin liberation. After 12 months of storage, active retention remained above 93% in the lead embodiment but fell sharply in several comparators. To position these results within the broader literature, we reviewed representative peer-reviewed and official-source data showing that EGT is absorbed and well tolerated in humans, piperine markedly increases curcumin exposure in human volunteers, curcumin–piperine co-supplementation can improve oxidative-stress endpoints in randomized trials, and core–shell co-delivery systems improve protection and controlled release. Together, these findings support BCLC as a differentiated antioxidant and anti-inflammatory raw-material platform with strong formulation logic and translational potential.
Zitieren
APA
Ziraoui, N., Whitmore, S., & Blake, M. (2026). BCLC Ergothioneine–Curcumin–Piperine Core–Shell Nanolipid Carrier for Synchronized Release, Improved Stability, and Translational Antioxidant–Anti-Inflammatory Synergy. International Journal of Agriculture and Food Sciences Research, 4(1), 83-92. https://doi.org/10.62051/ijafsr.v4n1.08
Vancouver
Ziraoui N, Whitmore S, Blake M. BCLC Ergothioneine–Curcumin–Piperine Core–Shell Nanolipid Carrier for Synchronized Release, Improved Stability, and Translational Antioxidant–Anti-Inflammatory Synergy. International Journal of Agriculture and Food Sciences Research. 2026;4(1):83-92. doi:10.62051/ijafsr.v4n1.08
BibTeX
@article{Ziraoui2026,
author = {Ziraoui, Nour-Eddine and Whitmore, Sebastian and Blake, Madison},
title = {BCLC Ergothioneine–Curcumin–Piperine Core–Shell Nanolipid Carrier for Synchronized Release, Improved Stability, and Translational Antioxidant–Anti-Inflammatory Synergy},
journal = {International Journal of Agriculture and Food Sciences Research},
year = {2026},
volume = {4},
number = {1},
pages = {83--92},
doi = {10.62051/ijafsr.v4n1.08}
}
EUVIMED